Because LRRK2 mutation carriers present symptoms and brain pathology very similar to idiopathic PD (1–4), understanding the biological role of LRRK2 could help to uncover new therapeutic strategies for both inherited and sporadic cases. The gene discussed is LRRK2; the disease is Parkinson disease.